Senior Director, Global Commercial Development
New
R
Revolution MedicinesOncology pharmaceuticals
Remote (United States)Full-TimeDirector
Salary232,000 - 290,000 USD per year
Apply NowOpens the employer's application page
Job Details
- Experience
- Bachelor’s degree with at least 15 years, or advanced degree with at least 8 years, of progressive commercial experience in a biotechnology and/or pharmaceutical company
- Required Skills
- Cross-functional Team Leadership
Requirements
- Hold a bachelor’s degree with at least 15 years, or an advanced degree with at least 8 years, of progressive commercial experience in biotechnology or pharmaceuticals.
- Bring strategic marketing experience; sales experience is preferred.
- Have proven success developing global oncology commercial strategies across products, indications, or stages of disease.
- Demonstrate experience influencing complex cross-functional product teams.
- Be able to develop patient and revenue forecasts, interpret market and clinical insights, and evaluate strategic trade-offs.
- Bring strong clinical and scientific acumen, including the ability to translate clinical evidence, trial design, and oncology treatment pathways into commercial implications.
- Demonstrate leadership and the ability to build teams and partnerships and influence without direct authority.
- Have strong organizational and prioritization skills and deliver strategic work under evolving timelines.
- Have executive communication, presentation, and external stakeholder engagement skills.
- Be available for up to 40% travel.
- Preferred: experience in pancreatic or other gastrointestinal cancers, including first-line metastatic and earlier-stage settings.
- Preferred: experience with precision oncology, KRAS/RAS-targeted medicines, molecular testing, or biomarker-defined populations.
- Preferred: experience with oncology launches, indication expansion, lifecycle management, and global or regional commercial organizations.
Responsibilities
- Lead global commercial development across pancreatic cancer therapeutic settings and connect indication strategies to portfolio value.
- Evaluate clinical and commercial opportunities, unmet need, competitive differentiation, treatment sequencing, and investment trade-offs.
- Develop commercial hypotheses for first-line, locally advanced, surgical/perioperative, and adjuvant treatment settings.
- Partner with product teams on daraxonrasib and zoldonrasib positioning, biomarker-defined populations, and potential combination approaches.
- Develop global epidemiology, treatment-flow, patient-segmentation, revenue, and sensitivity models.
- Collaborate with Clinical Development, Medical Affairs, HEOR, and Market Access on target populations, endpoints, standards of care, and evidence needs.
- Work with Precision Medicine and Diagnostics on RAS/KRAS testing, patient identification, laboratory and referral workflows, and access.
- Coordinate with regional affiliates, global brand teams, and existing indication teams on strategy and launch readiness.
- Develop commercialization frameworks, value propositions, brand positioning, affiliate readiness, access assumptions, and launch scenarios.
- Monitor scientific milestones, competing programs, diagnostic adoption, and treatment patterns; guide cross-functional teams and communicate recommendations to senior leaders.
View Full Description & ApplyYou'll be redirected to the employer's site
